News: Brokerage

Savills adds to life sciences team with addition of Schifrin

Manhattan, NY Savills has hired Jonathan Schifrin as senior managing director in its New York office. The addition will expand Savills life sciences capabilities and biotech tenant advisory services across the New York region.

Schifrin joins the firm from CBRE, where he was senior vice president. He also held positions at Transwestern and JLL, where he focused on representing tenants and landlords in the office and life sciences industry. Throughout his career, he has represented over 7,500,000 s/f of rentable space and completed more than 1,500,000 s/f of client leasing transactions.

“New York is a burgeoning hub and critical market for life sciences with the city investing heavily in its development,” said vice chairman and head of Savills life sciences team Austin Barrett. “As the supply of available lab space continues to grow, tenants seek expert guidance as they scale and seek new integrated lab workplace opportunities. Jonathan will collaborate with our national team to help life sciences companies leverage real estate to get products and therapies to patients quicker and more cost-effectively.”

As a senior managing director, Schifrin will focus on growing the firm’s tenant advisory services across the region and partner with local markets throughout the US on new business development. He will additionally serve as an advisor to clients, providing the entire platform of Savills life sciences capabilities and solutions.

MORE FROM Brokerage

REALM, DelShah Capital and A.M. Properties acquire 377,000 s/f CitySpire office condominium

Manhattan, NY REALM, in partnership with DelShah Capital and A.M. Properties, acquired  CitySpire, a 377,000 s/f office condominium comprising 24 floors within the 70-story tower at 156 W 56th St. in Midtown. Adjacent to Central Park with transit access and amenities, CitySpire is a Class A office asset located in one of the city’s most sought-after office corridors.
READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
A fresh start - by Shallini Mehra and Amit Doshi

A fresh start - by Shallini Mehra and Amit Doshi

For the past several years, the New York City multifamily housing market has been defined by disruption. The combined impact of the HSTPA rent laws and a sharply higher interest rate environment has fundamentally reduced
The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking
Tri-state capital  migrates nationally amid  regulation pressure - by Reese Weaver

Tri-state capital migrates nationally amid regulation pressure - by Reese Weaver

New York tri-state multifamily investors are increasingly reallocating capital to less-regulated markets across the U.S. as rent control and legislative risk erode returns at home. With over 60% of New York City’s rental housing stock classified as rent-stabilized, the traditional value-add model — buying under-performing buildings,

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

July 1, 2025 is the deadline for US banks to begin to adopt Basel III banking standards and July 14, 2025 is the deadline for U.S. banks to adopt ISO 20022 messaging standards. Both will have a significant effect on the banking and commercial real estate (CRE) finance sectors.